These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 14466606)

  • 21. [A new vasodilator in the functional therapy of peripheral arteriopathies: 1-(p-hydroxyphenyl)-2-(1-methyl-2-phenoxyethylamino)-propanol HC1].
    FERRANTE G; GRASS IM; NEGRO G
    Minerva Cardioangiol; 1960 Jun; 8():288-95. PubMed ID: 13822372
    [No Abstract]   [Full Text] [Related]  

  • 22. Effects of cyclandelate (cyclospasmol) in treatment of circulatory disturbances.
    LESLIE RE
    Tex State J Med; 1960 May; 56():352-6. PubMed ID: 14415999
    [No Abstract]   [Full Text] [Related]  

  • 23. [Therapeutic trial of a vasodilator in arteriopathy of the extremities. Evaluation of results and discussion on the use of vasodilators in arteritis].
    PIERRON J
    Mars Med; 1960; 97():641-5. PubMed ID: 14432867
    [No Abstract]   [Full Text] [Related]  

  • 24. [First notes on the use of a new vasodilator, Caa 40, in leg ulcers].
    DUGOIS P; COLOMB L; GAGNAIRE J
    Bull Soc Fr Dermatol Syphiligr; 1959; 66():213-4. PubMed ID: 13818502
    [No Abstract]   [Full Text] [Related]  

  • 25. [Use of a product of esterification of mandelic acid with 3,5,5-triethylcyclohexanol (cyclospasmol) in the treatment of peripheral arteriopathy].
    STARACE G; NOFERI A; PADULA R
    Gazz Med Ital; 1960 Apr; 119():133-6. PubMed ID: 13833815
    [No Abstract]   [Full Text] [Related]  

  • 26. [Observations on a new synthetic coronary vasodilator].
    TRALDI A; TINCANI GP
    Minerva Med; 1962 Jun; 53():1747-50. PubMed ID: 13922271
    [No Abstract]   [Full Text] [Related]  

  • 27. [On the therapy of coronary insufficiency].
    DUETSCH L
    Ther Ggw; 1960 May; 99():228-34. PubMed ID: 13818454
    [No Abstract]   [Full Text] [Related]  

  • 28. [Treatment of coronary insufficiency with 2,6-bis(diethanolamino)-4,8-dipiperidino-pyrimido-(5,4-d)-pyrimidine].
    AGOTE POVEDA IP; VILLANUEVA EDO A; ALONSOLOMAS L; ARIAS MARTINEZ JL; SARRALDE G
    Rev Clin Esp; 1960 Dec; 79():181-9. PubMed ID: 13681671
    [No Abstract]   [Full Text] [Related]  

  • 29. [Actein, a fluid extract from Actaea racemosa, in the medical therapy of peripheral arteriopathies].
    STARACE G; NOFERI A; SALDAMARCO G
    Clin Ter; 1962 May; 22():823-9. PubMed ID: 13916295
    [No Abstract]   [Full Text] [Related]  

  • 30. [Clinical and experimental studies on persantin in coronary diseases].
    GREIF S
    Wien Med Wochenschr; 1960 Jun; 110():463-6. PubMed ID: 13851721
    [No Abstract]   [Full Text] [Related]  

  • 31. [Importance of a new synthetic vasodilator, Caa 40, in the treatment of chronic ulcers of the lower extremities].
    THIERS H; COLOMB D; FAYOLLE J; ARCADIO F; NOVE JOSSERAND
    Bull Soc Fr Dermatol Syphiligr; 1959; 66():217-21. PubMed ID: 13837804
    [No Abstract]   [Full Text] [Related]  

  • 32. [Clinical study of a synthetic coronary vasodilator, L 2329].
    JORIS H; SCHMETZ J
    Rev Med Liege; 1961 Sep; 16():486-9. PubMed ID: 13790720
    [No Abstract]   [Full Text] [Related]  

  • 33. A clinical study of a musculotropic vasodilating compound.
    SHAFTEL HE; SAMUELS S; PADERNACHT E
    Angiology; 1961 Sep; 12():423-6. PubMed ID: 13750570
    [No Abstract]   [Full Text] [Related]  

  • 34. Speripheral vascular disease in general practice. Some experiences with meso-inositol-hexanicotinate.
    HAMILTON RR
    Practitioner; 1960 Mar; 184():367-9. PubMed ID: 14399278
    [No Abstract]   [Full Text] [Related]  

  • 35. [Criteria of the efficacy of the treatment of coronary disease: "the coronary vasodilators"].
    CLOAREC M
    Sem Hop Ther Paris; 1961 Oct; 37():753-4. PubMed ID: 13879970
    [No Abstract]   [Full Text] [Related]  

  • 36. [On new possibilities in the therapy of coronary circulation disorders].
    LAUENROTH G
    Bull Off Chambre Synd Med Seine; 1960 Aug; 55():1434-5. PubMed ID: 13759428
    [No Abstract]   [Full Text] [Related]  

  • 37. [On a new method of therapy of peripheral and cerebral circulatory disorders with 3-(methyioxyethylamino)-2-hydroxypropyltheophylline-beta-pyridinecarboxylic acid (complamin)].
    THIESEN J; FISCHER T
    Medizinische; 1959 Aug; 31-32():1427-32. PubMed ID: 13837851
    [No Abstract]   [Full Text] [Related]  

  • 38. [Treatment of coronary insufficiency with Persantin].
    RIEGLER E
    Wien Z Inn Med; 1961 Mar; 42():140-2. PubMed ID: 13741533
    [No Abstract]   [Full Text] [Related]  

  • 39. [Preliminary results in the treatment of coronary disease with segotonin].
    NEDELJKOVIC S; DORDEVIC BS
    Med Glas; 1961; 15():400-2. PubMed ID: 14478728
    [No Abstract]   [Full Text] [Related]  

  • 40. Studies with a new coronary vasodilator drug: persantin.
    KINSELLA D; TROUP W; McGREGOR M
    Am Heart J; 1962 Feb; 63():146-51. PubMed ID: 14456202
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.